SGHT Sight Sciences, Inc.
8.560USD-4.04%Mkt Cap: 471.55M $P/E: —2d ago
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The …
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap471.55M USD
Enterprise Value433.77M USD
Revenue (TTM)83.38M USD
Gross Profit66.67M USD
Net Income (TTM)-38.43M USD
Revenue/Share1.56 USD
Last Price8.560 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees186
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-19.81
PEG—
EV/EBITDA-22.52
EV/Revenue5.20
P/S5.66
P/B8.85
EPS (TTM)-0.54
EPS (Forward)-0.43
52W Range
3.19082% of range9.713
52W High9.713 USD
52W Low3.190 USD
Profitability
Gross Margin86.17%
Oper. Margin-16.62%
EBITDA Margin-23.11%
Profit Margin-49.67%
ROE-60.10%
ROA-33.33%
Growth
Revenue Growth19.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-29.69M USD
CapEx (TTM)224.00K USD
FCF Margin-10.33%
FCF Yield-1.83%
Net Debt-37.78M USD
Net Debt/EBITDA1.96
Balance Sheet
Debt/Equity0.64
Current Ratio4.95
Quick Ratio4.45
Book Value/Sh0.97 USD
Cash/Share1.45 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)9.400 USD
Upside (mean)+9.8%
Target Range8.000 USD – 12.00 USD
8.000+9.8% to mean12.00
# Analysts5
Ownership
Shares Out.55.09M
Float35.59M
Insiders20.06%
Institutions52.42%
Short Interest
Short Ratio6.6d
Short % Float3.12%
Short % Out.2.27%
Shares Short1.25M
Short (prev mo.)883.65K
Technical
SMA 507.868 (+8.8%)
SMA 2005.901 (+45.1%)
Beta2.45
S&P 52W Chg16.45%
Avg Vol (30d)280.43K
Avg Vol (10d)406.17K
Technical Indicators
RSI (14)53.7
MACD0.3737
MACD Signal0.4479
MACD Hist.-0.0742
BB Upper9.466 USD
BB Middle8.550 USD
BB Lower7.634 USD
BB Width21.43%
ATR (14)0.4375 USD
Vol Ratio (20d)1.07x